What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

Marta Vives-Pi, Irma Pujol-Autonell

Research output: Contribution to journalReview articleResearchpeer-review

Original languageEnglish
Pages (from-to)2955-2958
JournalNanomedicine
Volume10
Issue number19
DOIs
Publication statusPublished - 1 Oct 2015

Keywords

  • autoimmunity
  • immunotherapy
  • liposomes
  • nanomedicine
  • Type 1 diabetes

Cite this